On 30 October 2014
Glenmark Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 October 2014 to consider and approve the Company's Unaudited Financial Statements for the Second Quarter/Half year ended 30 September, 2014 (Q2).Powered by Capital Market - Live News
